BIOPHARMX CORPORATION WARRANT TO PURCHASE COMMON STOCK Share[Read on via official release] Source: US SECView full document:8-K_for_BioPharmX_Corp_8-K-11-21-2018
Vanda Announces Positive Pivotal Study Results for HETLIOZ® (tasimelteon) in Patients with Smith-Magenis Syndrome industryview December 11, 2018
